Join world-leading scientists as they present their recent research and perspectives in the exciting, fast-moving field of Targeted Protein Degradation. This free symposium will cover topics from PROTACs, to LYTACs and DUBTACs, as well as innovative new research tools and techniques that are helping to advance the field.

Prof. Daniel Nomura Professor of Chemical Biology, University of California, Berkeley

		Dr. Gesine Veits Senior Scientist C4 Therapeutics

		Dr. Andrea Testa Head of Chemistry Amphista Therapeutics

		Dr. Katherine Donovan Senior Scientist Dana-Farber Cancer Institute

		Ms Green Ahn Graduate student Stanford University

		Dr. Shanique Alabi Scientist Monte Rosa Therapeutics

Dr. Hannah Maple Innovation Manager Bio-Techne

AGENDA

TIME (BST/EDT)	SPEAKER	TALK TITLE
3pm / 10am	Dr. Hannah Maple Bio-Techne	Welcome and Introduction
3.10pm / 10.10am	Dr. Katherine Donovan Dana-Farber Cancer Institute	Chemoproteomic Profiling Surveys the Degradable Proteome
3.35pm / 10.35am	Dr. Shanique Alabi Monte Rosa Therapeutics	Mutant-Selective Degradation by BRAF-Targeting PROTACs
4pm / 11am	Dr. Gesine Veits C4 Therapeutics	Development of an AchillesTAG Degradation System and its Application to Control CAR-T Activity
SHORT BREAK
4.30pm / 11.30am	Dr. Andrea Testa Amphista Therapeutics	Next Generation Targeted Protein Degradation
4.55pm / 11.55am	Ms Green Ahn Stanford University	Lysosome Targeting Chimeras (LYTACs) that Engage the Liver-Specific Receptor for Targeted Protein Degradation through the Endolysosomal Pathway
5.20pm / 12.20pm	Prof. Daniel Nomura  University of California, Berkeley	Reimagining Druggability using Chemoproteomic Platforms
5.50pm / 12.50pm	Dr. Hannah Maple Bio-Techne	Closing Remarks